Vetigenics
Philadelphia, Pennsylvania, United States · Biotechnology, Health Care, Therapeutics · 10 employees
Vetigenics is a clinical-stage animal health biotechnology company focused on advancing targeted antibody therapies for pets. Utilizing its proprietary CANIBODY™ technology, Vetigenics develops superior antibodies for conditions affecting animals based on successful human treatments. The company collaborates with global animal health partners and institutions like the National Cancer Institute to
Funding history
- Series seed — $6.0M — Feb 2025
Recent signals
- Feb 03, 2025: Raised $6.0M in Series seed
See plans & pricing → Track Vetigenics’s funding, hiring, and signals — with verified contacts — on Fundz.